Cambridge Cognition Plc (AIM: COG) is an international digital neuroscience company developing and marketing validated software technologies to enhance research into brain health, optimise R&D productivity and precisely quantify cognition in patients worldwide.
Our cognitive assessment technologies for mobile, wearable, and online platforms accelerate the development of new treatments, maximise efficiency and data quality throughout research, and improve health outcomes.
Our digital health products have been used for over 30 years in thousands of academic and industry clinical trials by the world's leading pharmaceutical and biotech companies, academic institutions and health organisations.
This profile was automatically created. Find out more about [companyname] on their company website or check out their opportunities in the opportunities section of this page.